1887

Abstract

Very little is known about the occurrence and various types of extended-spectrum β-lactamase (ESBL), AmpC and carbapenemase in Iran. The aims of this study were to determine the prevalence of ESBLs, AmpCs and carbapenemase genes among in Azerbaijan and to characterize the genetic composition of the detected genes. A total of 307 isolates, recovered from five medical centres, were screened for ESBL, AmpC and carbapenemase activities by the disc diffusion method and phenotypic confirmatory tests. The 162 selected strains (third-generation cephalosporins, cefoxitin- or carbapenem-resistant strains with positive or negative phenotypic confirmatory tests) were selected for multiplex PCR screening for β-lactamase genes, and detected genes were confirmed by sequencing. Of 162 isolates, 156 harboured 1 to 6 β-lactamase genes of 41 types. The most prevalent genes were (29.9 %), followed by (25.7 %). Plasmid-mediated AmpC was detected in 66 strains (21.5 %) alone or in combination with other genes. Carbapenemase-encoding genes were detected in 18 strains (5.8 %) of 27 carbapenem-non-susceptible isolates including 11, 7, 3 and 1 cases of , , and genes, respectively. Interestingly, 148 (94.8 %) of 156 strains with any β-lactamase gene were found to have a multidrug-resistant pattern. The rate of resistance to β-lactams and multidrug-resistant is high in Azerbaijan. All positive strains for carbapenemase genes were resistant to all β-lactams. The present study reveals the high occurrence of CTX-M-type ESBLs followed by TEM and SHV variants among isolates. East Azerbaijan seems to be an alarming focus for OXA-48, NDM-1 and KPC dissemination.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000356
2016-11-16
2020-01-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/11/1322.html?itemId=/content/journal/jmm/10.1099/jmm.0.000356&mimeType=html&fmt=ahah

References

  1. Bradford P. A., Bratu S., Urban C., Visalli M., Mariano N., Landman D., Rahal J. J., Brooks S., Cebular S. et al. 2004; Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis39:55–60 [CrossRef][PubMed]
    [Google Scholar]
  2. CLSI 2012; Performance Standards for Antimicrobial Susceptibility Testing 22nd Informational SupplementM100–S22 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  3. CLSI 2015; Performance Standards for Antimicrobial Susceptibility Testing 25th Informational Supplement M100–S25 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  4. Cantón R., Coque T. M.. 2006; The CTX-M beta-lactamase pandemic. Curr Opin Microbiol9:466–475[CrossRef]
    [Google Scholar]
  5. Castanheira M., Mendes R. E., Woosley L. N., Sader H., Fritsche T., Jones R. N.. 2008; Emergence of bla CTX-M among Enterobacteriaceae isolates. In U. S. A. Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, Abstr. C1-113. Abstr. 48th Intersci. Conf. Antimicrob Agents Chemother. (ICAAC)-Infect. Dis. Soc. Am. (IDSA) 46th Annu. Meet Washington, DC: American Society for Microbiology and Infectious Diseases Society of America;
    [Google Scholar]
  6. Castanheira M., Farrell S. E., Deshpande L. M., Mendes R. E., Jones R. N.. 2013; Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob Agents Chemother57:3012–3020 [CrossRef][PubMed]
    [Google Scholar]
  7. Castanheira M., Farrell S. E., Krause K. M., Jones R. N., Sader H. S.. 2014; Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups. Antimicrob Agents Chemother58:833–838 [CrossRef][PubMed]
    [Google Scholar]
  8. Dallenne C., Da Costa A., Decré D., Favier C., Arlet G.. 2010; Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Anti microb Chemother65:490–495[CrossRef]
    [Google Scholar]
  9. Feizabadi M. M., Delfani S., Raji N., Majnooni A., Aligholi M., Shahcheraghi F., Parvin M., Yadegarinia D.. 2010; Distribution of bla TEM, bla SHV, bla CTX-M genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad hospital, Tehran, Iran. Microb Drug Resist16:49–53 [CrossRef][PubMed]
    [Google Scholar]
  10. Jacoby G. A.. 2009; AmpC beta-lactamases. Clin Microbiol Rev22:161–182[CrossRef]
    [Google Scholar]
  11. Japoni-Nejad A., Ghaznavi-Rad E., van Belkum A.. 2014; Characterization of plasmid-mediated AmpC and carbapenemases among Iranain nosocomial isolates of Klebsiella pneumoniae using phenotyping and genotyping methods. Osong Public Health Res Perspect5:333–338 [CrossRef][PubMed]
    [Google Scholar]
  12. Marchaim D., Gottesman T., Schwartz O., Korem M., Maor Y., Rahav G., Karplus R., Lazarovitch T., Braun E. et al. 2010; National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother54:5099–5104 [CrossRef][PubMed]
    [Google Scholar]
  13. Moosavian M., Deiham B.. 2012; Distribution of TEM, SHV and CTX-M genes among ESBL-producing Enterobacteriaceae isolates in Iran. Afr J Microbiol Res6:5433–5439 [CrossRef]
    [Google Scholar]
  14. Nematzadeh S., Shoeib N., Shahcheraghi F., Fereshteh S., Feizabadi M. M., Mehdi F. M., Nikbin V. S., Sadat N. V., Nasehi L., Leila N.. 2011; Molecular characterization of CTX-M β-lactamases among Klebsiella pneumoniae isolated from patients at Tehran hospitals. Indian J Med Microbiol29:254 [CrossRef][PubMed]
    [Google Scholar]
  15. Nordmann P., Naas T., Poirel L.. 2011a; Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis17:1791–1798 [CrossRef][PubMed]
    [Google Scholar]
  16. Nordmann P., Poirel L., Walsh T. R., Livermore D. M.. 2011b; The emerging NDM carbapenemases. Trends Microbiol19:588–595 [CrossRef]
    [Google Scholar]
  17. Paterson D. L., Bonomo R. A.. 2005; Extended-spectrum beta-lactamases: a clinical update. Clin Micro biol Rev18:657–686 [CrossRef]
    [Google Scholar]
  18. Queenan A. M., Bush K.. 2007; Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev20:440–458 [CrossRef][PubMed]
    [Google Scholar]
  19. Rezai M. S., Salehifar E., Rafiei A., Langaee T., Rafati M., Shafahi K., Eslami G.. 2015; Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in north of Iran. Bio Med Res Int2015:1–7 [CrossRef]
    [Google Scholar]
  20. Safari M., Shojapour M., Akbari M., Pourbabaee A., Abtahi H.. 2013; Dissemination of CTX-M-type beta-lactamase among clinical isolates of Enterobacteriaceae in Markazi province, Iran. Jundishapur J Microbiol6:e7182 [CrossRef]
    [Google Scholar]
  21. Shahcheraghi F., Nobari S., Rahmati Ghezelgeh F., Nasiri S., Owlia P., Nikbin V. S., Imani Fooladi A. A.. 2013; First report of New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae in Iran. Microb Drug Resist19:30–36 [CrossRef][PubMed]
    [Google Scholar]
  22. Sheng W. H., Badal R. E., Hsueh P. R.. SMART Program 2013; Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother57:2981–2988 [CrossRef][PubMed]
    [Google Scholar]
  23. Voets G. M., Fluit A. C., Scharringa J., Cohen Stuart J., Leverstein-van Hall M. A.. 2011; A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases. Int J Antimicrob Agents37:356–359 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000356
Loading
/content/journal/jmm/10.1099/jmm.0.000356
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error